Gabriela Koifman

Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers

Hilla Solomon, Nathan Dinowitz, Ioannis S. Pateras et al. · Oncogene · 2018 · 116 citations · Full text

Mutant P53, Medicine, Stem Cells +14

USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer

Jessica K. Nelson, May Zaw Thin, Theodore Evan et al. · Nature Communications · 2022 · 90 citations · Full text

GREM1 is required to maintain cellular heterogeneity in pancreatic cancer

Linxiang Lan, Theodore Evan, Huafu Li et al. · Nature · 2022 · 78 citations

Tumor Biology, Pancreatic Cancer, Cellular Heterogeneity +7

Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation

Noa Rivlin, Shir Katz, Maayan Doody et al. · Proceedings of the National Academy of Sciences · 2014 · 52 citations · Full text

Mutant Escs, Cell Specialization, Tumor Biology +19

The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele

Yoav Shetzer, Sivan Kagan, Gabriela Koifman et al. · Cell Death and Differentiation · 2014 · 41 citations · Full text

Embryonic Stem Cell, Genome Instability, Lineage Plasticity +9